A detailed history of Truist Financial Corp transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 6,443 shares of LNTH stock, worth $562,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,443
Previous 11,570 44.31%
Holding current value
$562,602
Previous $928,000 23.81%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$77.7 - $123.62 $398,367 - $633,799
-5,127 Reduced 44.31%
6,443 $707,000
Q2 2024

Aug 20, 2024

SELL
$58.87 - $83.05 $281,398 - $396,979
-4,780 Reduced 29.24%
11,570 $928,000
Q1 2024

May 10, 2024

BUY
$51.07 - $68.26 $29,263 - $39,112
573 Added 3.63%
16,350 $1.02 Million
Q4 2023

Feb 02, 2024

SELL
$55.6 - $77.89 $46,759 - $65,505
-841 Reduced 5.06%
15,777 $978,000
Q3 2023

Nov 14, 2023

SELL
$60.27 - $90.75 $109,209 - $164,439
-1,812 Reduced 9.83%
16,618 $1.15 Million
Q2 2023

Aug 01, 2023

SELL
$82.41 - $99.65 $80,349 - $97,158
-975 Reduced 5.02%
18,430 $1.55 Million
Q1 2023

May 05, 2023

BUY
$47.76 - $82.86 $301,508 - $523,095
6,313 Added 48.22%
19,405 $1.6 Million
Q4 2022

Feb 17, 2023

BUY
$48.76 - $77.67 $314,014 - $500,194
6,440 Added 96.81%
13,092 $667,000
Q3 2022

Oct 26, 2022

BUY
$61.42 - $86.29 $101,957 - $143,241
1,660 Added 33.25%
6,652 $468,000
Q2 2022

Jul 22, 2022

SELL
$55.54 - $72.65 $6,053 - $7,918
-109 Reduced 2.14%
4,992 $330,000
Q1 2022

Apr 22, 2022

BUY
$24.28 - $56.64 $123,852 - $288,920
5,101 New
5,101 $283,000
Q2 2020

Aug 14, 2020

SELL
$10.34 - $15.51 $171,612 - $257,419
-16,597 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $37,214 - $81,904
4,085 Added 32.65%
16,597 $212,000
Q4 2019

Feb 14, 2020

BUY
$18.47 - $24.03 $231,096 - $300,663
12,512 New
12,512 $256,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.